PMID: 17244607

Zegarra-Moran O, Monteverde M, Galietta LJ, Moran O
Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators. Interaction between activation and inhibition.
J Biol Chem. 2007 Mar 23;282(12):9098-104. Epub 2007 Jan 23., 2007-03-23 [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:5:76
status: NEW
view ABCC7 p.Arg553Gln details
We found that all three mutants responded to cAMP, although the affinity of R553Q was higher than that of wild type CFTR. Login to comment
6 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:6:3
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:6:13
status: NEW
view ABCC7 p.Val1293Gly details
In R553Q and V1293G mutants, the dissociation constant of potentiators for the activating site was increased, whereas the dissociation constant for the inhibitory site was reduced. Login to comment
37 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:37:90
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 17244607:37:100
status: NEW
view ABCC7 p.Gly1349Asp details
Printed in the U.S.A. 9098 tion that mutations in conserved residues of the NBDs such as G551D and G1349D exhibit a shift in the affinity for potentiators (5, 15-18). Login to comment
41 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:41:212
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 17244607:41:223
status: NEW
view ABCC7 p.Gly1349Asp details
After in silico docking of several compounds, we compared the theoretical binding free energy measured on the model, with the experimental binding free energy obtained from dissociation constants from wild type, G551D, and G1349D proteins. We found a good correlation between these two parameters for a putative binding site located in the interface of the NBD1-NBD2 dimer, embedded in a cavity on NBD1, and interacting also with the NBD2 surface. Login to comment
44 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:44:69
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:44:79
status: NEW
view ABCC7 p.Val1293Gly details
We found that the stimulating effect of potentiators was reduced for R553Q and V1293G. Login to comment
49 ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:49:7
status: NEW
view ABCC7 p.Val1293Gly details
Mutant V1293G was introduced in a wild type CFTR construct contained in the expression vector pTracer-CMV (15) by a recombinant PCR method. Login to comment
50 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:50:24
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:50:14
status: NEW
view ABCC7 p.Ala554Glu details
For mutations A554E and R553Q, CFTR cDNA was subcloned on pcDNA3.1. Login to comment
52 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:52:85
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:52:0
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:52:75
status: NEW
view ABCC7 p.Ala554Glu details
V1293G clones were selected and maintained in 800 ␮g/ml Zeocin, and A554E and R553Q constructs were selected and maintained in 1 mg/ml G418. Login to comment
53 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:53:69
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:53:51
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:53:59
status: NEW
view ABCC7 p.Ala554Glu details
Cell Cultures-FRT cells expressing wild type (WT), V1293G, A554E, or R553Q CFTR were cultured on 60-mm Petri dishes with Coon`s modified F12 containing 5% fetal bovine serum, 2 mM L-glutamine, 50 units/ml penicillin, and 50 ␮g/ml streptomycin and selection antibiotics, as described previously (15). Login to comment
85 ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:85:58
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:85:69
status: NEW
view ABCC7 p.Ala554Glu details
The apparent dissociation constant of CPTcAMP for mutants V1293G and A554E was not statistically different from that of the wild type protein (Fig. 2). Login to comment
86 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:86:42
status: NEW
view ABCC7 p.Arg553Gln details
Conversely, the dissociation constant for R553Q was significantly smaller. Login to comment
98 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:98:59
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:98:33
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:98:22
status: NEW
view ABCC7 p.Ala554Glu details
Continuous lines (WT, A554E, and V1293G) and broken lines (R553Q) indicate fitting of the data to Equation 1. Login to comment
99 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:99:157
status: NEW
view ABCC7 p.Gly551Asp details
TABLE 1 Parameters obtained from the fit to Equation 1 of CPTcAMP dose-response relationship on wild type and mutant CFTRs For comparison, the parameters of G551D, a severe CF-causing mutation, are included. Login to comment
100 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:100:29
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:100:23
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:100:16
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:100:10
status: NEW
view ABCC7 p.Ala554Glu details
Wild type A554E V1293G R553Q G551D n ϭ 5 n ϭ 4 n ϭ 4 n ϭ 6 n ϭ 7 Imax (␮A/cm2 ) 282.2 Ϯ 13.5 66.9 Ϯ 16.4a 70.2 Ϯ 14a 93.8 Ϯ 19a 10.1 Ϯ 2.8a Kd (␮M) 54.2 Ϯ 11.5 40.5 Ϯ 5.9 48.4 Ϯ 13.5 21.5 Ϯ 4.5a 74.2 Ϯ 12.1 I(20)/I(max) 0.3 Ϯ 0.04 0.34 Ϯ 0.03 0.32 Ϯ 0.05 0.51 Ϯ 0.05a 0.23 Ϯ 0.03 a p Ͻ 0.05. Login to comment
102 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:102:177
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:102:112
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:102:123
status: NEW
view ABCC7 p.Ala554Glu details
It is interesting to note that 20 ␮M CPTcAMP produced a similar current fraction (ϳ0.3) on mutants V1293G and A554E but half of the maximum current (ϳ0.5) on R553Q (see I(20)/ I(max) in Table 1), in agreement with the lower Kd of CPT-cAMP found on this mutant. Login to comment
107 ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:107:23
status: NEW
view ABCC7 p.Ala554Glu details
The response of mutant A554E to genistein, with almost no change on Ka or Ki, was similar to the response of wild type CFTR. Login to comment
108 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:108:60
status: NEW
view ABCC7 p.Arg553Gln details
In contrast, the protein with the adjacent residue mutated, R553Q, behaved in a completely different way. Login to comment
110 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:110:45
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:110:7
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:110:35
status: NEW
view ABCC7 p.Ala554Glu details
Mutant V1293G behavior was between A554E and R553Q. Login to comment
111 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:111:77
status: NEW
view ABCC7 p.Arg553Gln details
In fact, the two equilibrium constants were modified but less than in mutant R553Q (Table 2). Login to comment
113 ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:113:152
status: NEW
view ABCC7 p.Val1293Gly details
In general, for these compounds Ka changed on mutants in the same direction as Ka for genistein; however, the effect was less marked, except for mutant V1293G, which tended to be more sensitive to Act-06 (see Table 2). Login to comment
120 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:120:101
status: NEW
view ABCC7 p.Arg553Gln details
In fact, the more the Ka value shifted toward higher concentrations, as in the case of genistein for R553Q, the more the Ki value shifted toward lower concentrations. Login to comment
123 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:123:75
status: NEW
view ABCC7 p.Arg553Gln details
A, representative traces showing the response of wild type CFTR and mutant R553Q to application of genistein. Login to comment
127 ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:127:92
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:127:99
status: NEW
view ABCC7 p.Ala554Glu details
C-E, comparison of normalized and averaged genistein dose-response relationships of mutants V1293G,A554E,andR553Q(seesymbolkeys)toWT(dashedlines).Eachsymbol is the mean of 4-6 experiments, and vertical bars show S.E. Login to comment
130 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:130:253
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:130:520
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:130:782
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:130:190
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:130:457
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:130:718
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:130:127
status: NEW
view ABCC7 p.Ala554Glu details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:130:393
status: NEW
view ABCC7 p.Ala554Glu details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:130:655
status: NEW
view ABCC7 p.Ala554Glu details
Compounds Protein n fA Ka Ki ␮M ␮M Genistein Wild type 5 1.33 Ϯ 0.41 3.08 Ϯ 0.74 562.4 Ϯ 111.1 A554E 6 2.75 Ϯ 0.62 4.58 Ϯ 0.51 408.6 Ϯ 84.8 V1293G 6 4.87 Ϯ 1.91 12 Ϯ 3.9a 270.5 Ϯ 36.4a R553Q 6 1.87 Ϯ 0.12 22.28 Ϯ 5.2a 119.9 Ϯ 34.9a UCCF029 Wild type 4 0.41 Ϯ 0.04 0.021 Ϯ 0.002 1036 Ϯ 523 A554E 4 1.56 Ϯ 0.45a 0.036 Ϯ 0.009 1519 Ϯ 651 V1293G 5 3.19 Ϯ 1.09 0.042 Ϯ 0.008 843 Ϯ 126 R553Q 5 1.08 Ϯ 0.17a 0.154 Ϯ 0.029a 547 Ϯ 99 Act-06 Wild type 5 0.8 Ϯ 0.17 0.69 Ϯ 0.33 439.6 Ϯ 108 A554E 4 1.67 Ϯ 0.42 0.74 Ϯ 0.25 319.1 Ϯ 42.4 V1293G 4 1.25 Ϯ 0.16 0.35 Ϯ 0.09 383.8 Ϯ 28.9 R553Q 6 1.77 Ϯ 0.47a 2.11 Ϯ 0.73 179.1 Ϯ 73.2a a Student`s t test indicated that these values were statistically different from those on WT CFTR with p Ͻ 0.05. Login to comment
149 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:149:75
status: NEW
view ABCC7 p.Arg553Gln details
Surprisingly, we found a lower equilibrium constant for CPT-cAMP on mutant R553Q (see Table 2). Login to comment
150 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:150:40
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:150:119
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:150:109
status: NEW
view ABCC7 p.Ala554Glu details
Mutations of NBDs, like the CF mutation G551D (see Table 1 and Ref. 15) or the other mutations studied here, A554E and V1293G, do not seem to change significantly the sensitivity of the protein to CPTcAMP. Login to comment
152 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:152:40
status: NEW
view ABCC7 p.Arg553Gln details
It is interesting to note that mutation R553Q is one of the CF mutations identified as ⌬Phe508 revertants (34). Login to comment
153 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:153:32
status: NEW
view ABCC7 p.Arg553Gln details
That means that introduction of R553Q mutation into human CFTR partially corrects the processing and gating defect caused by the ⌬Phe508 mutation, which has been suggested to modify the NBD1 surface that interacts with other CFTR domains (20). Login to comment
155 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:155:60
status: NEW
view ABCC7 p.Gly551Asp details
An even more marked reduction had been found previously for G551D (see Table 1 and Refs. Login to comment
156 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:156:64
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:156:132
status: NEW
view ABCC7 p.Gly551Asp details
15 and 18), but in that case we measured the expression of both G551D and wild type proteins. We concluded that the small amount of G551D current was due to a severe gating defect of the mutant and not to reduced expression levels, as confirmed by the reduced open channel probability estimated from single channel recording. Login to comment
159 ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:159:155
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:159:18
status: NEW
view ABCC7 p.Ala554Glu details
Conversion of the Ala554 residue to glutamic acid had little effect on the capability of potentiators to favor the conductive state, whereas conversion of Val1293 to glycine increased the Ka for genistein by 4-fold. Login to comment
163 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:163:93
status: NEW
view ABCC7 p.Arg553Gln details
In fact, the mutation that produced a stronger shift of the affinity for these compounds was R553Q, where the charge was eliminated. Login to comment
167 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:167:68
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:167:75
status: NEW
view ABCC7 p.Val1293Gly details
ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:167:83
status: NEW
view ABCC7 p.Ala554Glu details
The CFTR proteins are indicated in red, yellow, green, and blue for R553Q, V1293G, A554E and WT, respectively. Login to comment
169 ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:169:172
status: NEW
view ABCC7 p.Ala554Glu details
Mutations in Binding Site for CFTR Potentiators 9102 potentiators (see Fig. 1; the distance between these amino acids and potentiators is less than 3.6 Å, whereas in A554E this distance is larger), and therefore a modification of any of them is predicted to produce a strong effect on the activation dissociation constant. Login to comment
170 ABCC7 p.Ala554Glu
X
ABCC7 p.Ala554Glu 17244607:170:4
status: NEW
view ABCC7 p.Ala554Glu details
The A554E mutant is different. Login to comment
176 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 17244607:176:43
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Val1293Gly
X
ABCC7 p.Val1293Gly 17244607:176:53
status: NEW
view ABCC7 p.Val1293Gly details
Actually, we found that an increased Ka in R553Q and V1293G with respect to wild type CFTR is accompanied by a reduced Ki (Figs. Login to comment
186 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 17244607:186:85
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 17244607:186:270
status: NEW
view ABCC7 p.Gly1349Asp details
Probably, the NBD with higher affinity for potentiators is NBD1, because CF mutation G551D, situated on NBD1 near the potentiator binding site, causes a more pronounced effect on the equilibrium constant for the activation site than the symmetrical CF mutation on NBD2, G1349D (16). Login to comment